Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
SOLID
Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection
1 other identifier
observational
1,980
1 country
68
Brief Summary
Observational, retrospective data collection and prospective IgG analysis, and multicenter study. The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
68 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2020
CompletedFirst Submitted
Initial submission to the registry
May 25, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedFebruary 9, 2026
June 1, 2022
2 years
May 25, 2020
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of the characteristics of patients
Description of the characteristics and evolution of patients with lung cancer who have contracted COVID-19 infection.
From the diagnosis of the COVID until the determination of the blood IgGs, up to 10 weeks
Secondary Outcomes (1)
Detection of antibodies (IgG) at 6 months after SARS-COV2 vaccines
From the date of complete SARS-COV2 vaccination administration until 6 month
Study Arms (1)
lung cancer+COVID-19
Lung cancer patients infected by COVID-19
Interventions
Eligibility Criteria
Patients who have not signed or do not wish to sign the informed consent for this study
You may qualify if:
- Patients diagnosed with lung cancer at any stage of the disease
- Age ≥ 18
- Patients who have signed the informed consent for this study
You may not qualify if:
- \. Patients who have not signed or do not wish to sign the informed consent for this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundación GECPlead
Study Sites (68)
Complejo Hospitalario de A Coruña
A Coruña, A Coruña, 15006, Spain
Hospital General Universitario de Elche
Elche, Alicante, 03203, Spain
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
ICO Hospitalet
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
Hospital Universitario de Burgos
Burgos, Burgos, Spain
Hospital Universitario Reina Sofía
Córdoba, Córdoba, 14004, Spain
Hospital Dr. Josep Trueta
Girona, Girona, 17007, Spain
Hospital Universitario Insular de Gran canaria
Las Palmas de Gran Canaria, Gran Canaria, 35016, Spain
Complejo Hospitalario de Jaén
Jaén, Jaén, 23007, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
Hospital Universitario 12 de Octubre
Madrid, Madrid, 28041, Spain
Hospital Universitario La Paz
Madrid, Madrid, 28046, Spain
Hospital Puerta de Hierro
Madrid, Madrid, 28222, Spain
Clínica Universidad de Navarra
Madrid, Madrid, Spain
Hospital de Sanchinarro
Madrid, Madrid, Spain
Hospital Severo Ochoa
Madrid, Madrid, Spain
Hospital Universitario Infanta Cristina
Madrid, Madrid, Spain
Hospital Universitario de Torrejón
Torrejón, Madrid, Spain
Hospital Universitario Son Llàtzer
Palma de Mallorca, Mallorca, 07198, Spain
Hospital General Universitario de Málaga
Málaga, Málaga, 29010, Spain
Complexo Hospitalario Universitario de Vigo
Vigo, Pontevedra, 36036, Spain
Hospital Virgen del Rocío
Seville, Sevilla, 41013, Spain
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Tenerife, Spain
Hospital Universitari i Politécnic La Fe
Valencia, Valencia, 46009, Spain
Hospital Clínico Universitario de Valencia
Valencia, Valencia, 46010, Spain
Hospital General de Valencia
Valencia, Valencia, 46014, Spain
Hospital Universitario Dr. Peset
Valencia, Valencia, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47003, Spain
Hospital La Esperanza
A Coruña, Spain
Hospital Universitario de Ferrol
A Coruña, Spain
Hospital Virgen de los Lirios
Alicante, Spain
Hospital Germans Trias i Pujol
Badalona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitari Dexeus
Barcelona, Spain
Hospital Universitario Cruces
Bilbao, Spain
Hospital Universitario Puerta del Mar
Cadiz, Spain
Hospital Universitario Puerto Real
Cadiz, Spain
Hospital Universitario San Pedro de Alcántara
Cáceres, Spain
Hospital General La Mancha Centro
Ciudad Real, Spain
Hospital Universitario de Vinalopó
Elche, Spain
Hospital Universitario de Guadalajara
Guadalajara, Spain
Complejo Asistencial Universitario de León
León, Spain
Hospital universitari Arnau de Vilanova
Lleida, Spain
Hospital San Pedro
Logroño, Spain
Hospital Universitario Lucus Augusti
Lugo, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Hospital Universitario de Móstoles
Madrid, Spain
Hospital Universitario del Henares
Madrid, Spain
Hospital Universitario Fundación Alcorcón
Madrid, Spain
Hospital Universitario Infanta Leonor
Madrid, Spain
Hospital Universitario Infanta Sofía
Madrid, Spain
Hospital Universitario Príncipe de Asturias
Madrid, Spain
Hospital Costa del Sol
Málaga, Spain
Complejo Hospitalario Universitario de Ourense Santa María Nai
Ourense, Spain
Hospital Universitario Son Espases
Palma de Mallorca, Spain
Clínica Universidad de Navarra
Pamplona, Spain
Complejo Hospitalario de Navarra
Pamplona, Spain
Hospital Universitario Sant Joan de Reus
Reus, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Hospital Universitario de Canarias
Santa Cruz de Tenerife, Spain
Hospital General de Segovia
Segovia, Spain
Hospital Sant Pau i Santa Tecla
Tarragona, Spain
Hospital Arnau de Vilanova
Valencia, Spain
Hospital de Manises
Valencia, Spain
Hospital General Universitario de Valencia
Valencia, Spain
Hospital Lluís Alcanyís
Valencia, Spain
Hospital Universitario Río Ortega
Valladolid, Spain
Complejo Hospitalario Zamora
Zamora, Spain
Related Publications (2)
Provencio M, Estival A, Franco F, Lopez-Vivanco G, Saigi M, Arasanz H, Diz P, Carcereny E, Garcia J, Aguado C, Mosquera J, Iruarrizaga E, Majem M, Bosch-Barrera J, Mielgo-Rubio X, Guirado M, Juan-Vidal O, Blasco A, Lucia Gozalvez C, Del Barrio A, De Portugal T, Lopez-Martin A, Serrano G, Campos B, Rubio J, Catot S, Esteban B, Marti-Ciriquian JL, Del Barco E, Calvo V; Spanish Lung Cancer Group (SLGC/GECP). Immunogenicity of COVID-19 vaccines in lung cancer patients. Lung Cancer. 2023 Oct;184:107323. doi: 10.1016/j.lungcan.2023.107323. Epub 2023 Aug 9.
PMID: 37639820DERIVEDProvencio M, Rodriguez-Abreu D, Ortega AL, Serrano G, Aguado C, Franco F, Gutierrez V, Lopez Vivanco G, Guirado M, Benitez G, Estival A, Calvo V, Jimenez B, Arasanz H, Coves J, Majem M, Massuti B, Vazquez S, Juan-Vidal O, Collazo-Lorduy A, Gozalvez CL, Del Barco E, Rosero A, Bosch-Barrerra J, Moreno MA, Mielgo-Rubio X, Villa JC, Lopez-Martin A, Cordoba JF, de Asis Aparisi F, Zafra M, Mosquera J, Perez Altozano J, Nadal E, Catot S, Balsalobre J, de Portugal T, Martin P, Cuesta de Juan S, Cobo M. Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study. Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504.
PMID: 35242627DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mariano Provencio, MD
Hospital Puerta de Hierro de Majadahonda de Madrid
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2020
First Posted
May 29, 2020
Study Start
April 15, 2020
Primary Completion
April 30, 2022
Study Completion
May 30, 2022
Last Updated
February 9, 2026
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share